PureTech Health (LON:PRTC) Share Price Crosses Below Fifty Day Moving Average – Should You Sell?

PureTech Health plc (LON:PRTC) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 146.56 ($1.86) and traded as low as GBX 140.40 ($1.78). PureTech Health shares last traded at GBX 142.25 ($1.80), with a volume of 205,632 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group reissued a “buy” rating and issued a GBX 455 ($5.77) price objective on shares of PureTech Health in a research report on Monday, December 16th.

PureTech Health Price Performance

The company has a market capitalization of £431.95 million, a P/E ratio of -5.90 and a beta of 1.02. The company’s 50-day moving average price is GBX 146.56 and its two-hundred day moving average price is GBX 154.55. The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51.

PureTech Health Company Profile

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.